WEST ORANGE, NJ -- (Marketwire) -- 01/27/12 -- Kathleen Martinez, Assistant
Secretary of Labor for the Office of Disability Employment Policy (ODEP),
came to Kessler Foundation on Friday to learn more about employment programs
supported by the Foundation and share her view on strategies for optimal
employment policies for individuals with disabilities. Her visit follows
Kessler Foundation's announcement of $2.7 million in grant funding to
disability employment initiatives across the nation.
"Kessler Foundation is the gas that fuels the programs that provide job
opportunities for people with disabilities," said Ms. Martinez. "The
Foundation's creativity, innovation and team-building serve as a catalyst for
creating sustainable employment options for the disability community."
Martinez heard from directors of seven programs, each with a different
approach to expandin... (more)
CHICAGO, Jan. 27, 2012 /PRNewswire-USNewswire/ -- Research Down Syndrome
(RDS), a nonprofit foundation that is among the leading sources for funding
of Down syndrome related cognitive research, is entering the second year
of its national running program, Race for the Extraordinary, to help
increase public awareness and funding for Down syndrome research. The
mission of RDS is the development of safe and effective therapies to address
the intellectual difficulties associated with Down syndrome.
Building on successful marathon and other race events during 2011 in major
cities,... (more)
WEST ORANGE, NJ -- (Marketwire) -- 01/24/12 -- Kessler Foundation awarded a
Signature Employment Grant in the amount of $425,000 to the Office of
Research Services at the University of Hawaii, to advance employment
opportunities for people with disabilities. This Grant is part of more than
$2.7 million in grants awarded in 2011. Since 2005, the Foundation has
awarded more than $20 million to innovative employment initiatives.
This Signature Employment Grant supports the development of a virtual reality
(VR) software application, EmployAble: A World Without Barriers, to help
jobs... (more)
HATFIELD, England, January 26, 2012 /PRNewswire/ --
Halaven® (eribulin) increases life expectancies for women with locally
advanced or metastatic breast cancer
Halaven® (eribulin), a novel treatment for patients with locally advanced or
metastatic breast cancer who have progressed after at least two
chemotherapeutic regimens for advanced disease, is now available under
national reimbursement in Italy. Prior therapy should have included two
common types of chemotherapy, an anthracycline and a taxane, unless patients
were not suitable for these treatments.[1] Eribulin is the first,... (more)
ABBOTT PARK, Illinois, January 25, 2012 /PRNewswire/ --
-- Fourth Quarter Ongoing EPS of $1.45, Up 11.5 Percent --
-- On Track to Separate into Two Leading Health Care Companies --
Abbott (NYSE: ABT) today announced financial results for the fourth quarter
ended Dec. 31, 2011.
Diluted earnings per share, excluding specified items, were $1.45, at the
high end of Abbott's previous guidance range, reflecting 11.5 percent growth.
Diluted earnings per share under Generally Accepted Accounting Principles
(GAAP) were $1.02, including specified items. Worldwide sales increased 4.1
percen... (more)
Subscribe to Disability Nexus Email News Alerts
Subscribe via RSS
Ulitzer content is offered under Creative Commons "Attribution Non-Commercial No Derivatives" License.
For any reuse or distribution, you must make clear to others the license terms of this work.
The best way to do this is with a link to this web page.
Any of the above conditions can be waived if you get written permission from Ulitzer, Inc., the copyright holder.
Nothing in this license impairs or restricts the author's moral rights.